News List

Haihe Pharmaceuticals' Paclitaxel Oral Solution China Marketing Authorization Application Officially Accepted
2022-09-15

On September 13, 2022, Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. and South Ko

Using artificial intelligence to detect Parkinson's disease by reading people's breathing patterns
2022-08-24

Parkinson's disease is notoriously difficult to diagnose because it relies primarily on the onse

Targeting specific DNA of Plasmodium may be effective in treating human malaria infection
2022-07-29

Targeting a parasite's DNA could be a more effective way to combat malaria, new research from th

Vijoice is the first FDA-approved PRS treatment
2022-07-07

2022.04.06, Novartis announced that the U.S. Food and Drug Administration (FDA) has granted accelera

Systemic lupus erythematosus (SLE) oral new drug! BMS Novel Oral TYK2 Inhibitor deucravicitinib
2022-06-14

Bristol-Myers Squibb (BMS) recently announced positive results from the Phase 2 PAISLEY study (NCT03

Takeda announced the Phase 3 SHP643 to evaluate the safety and pharmacokinetics of Takhzyro (lanadelumab)
2022-05-13

Takeda announced the Phase 3 SHP643 to evaluate the safety and pharmacokinetics of Takhzyro (lanadel

Bristol-Myers Squibb (BMS) presented 2-year data from the POETYK PSO long-term extension trial of the novel oral TYK2 inhibitor deucravacitinib
2022-05-13

Recently, Bristol-Myers Squibb (BMS) presented 2-year data from the POETYK PSO long-term extension t

AbbVie's oral JAK inhibitor Rinvoq (upatinib) approved by NMPA
2022-03-11

AbbVie recently announced that China’s National Medical Products Administration (NMPA) has approved

Genentech’s Evrysdi (risdiplam) Granted FDA Priority Review for Treatment of Pre-Symptomatic Babies Under 2 Months of Age With Spinal Muscular Atrophy (SMA)
2022-02-11

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (